Detalles de la búsqueda
1.
Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause.
Health Qual Life Outcomes
; 21(1): 126, 2023 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37990323
2.
Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?
Future Oncol
; 19(31): 2075-2082, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646326
3.
Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?
Future Oncol
; 2022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36226872
4.
Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Cancer
; 124(10): 2104-2114, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29505670
5.
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 77, 2018 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30189902
6.
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 84, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285696
7.
Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.
Adv Ther
; 41(6): 2233-2252, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38396203
8.
Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry.
Ophthalmol Ther
; 12(1): 325-340, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369619
9.
Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey.
Maturitas
; 167: 66-74, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36306669
10.
Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 21(4): 419-429, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842915
11.
Epidemiology and treatment patterns of UK women diagnosed with vasomotor symptoms: Findings from the Clinical Practice Research Datalink GOLD database.
Maturitas
; 164: 1-8, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738198
12.
Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States.
Maturitas
; 164: 38-45, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35785563
13.
Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 25(3): 524-530, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732856
14.
Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review.
Clin Ther
; 43(10): 1792-1818, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34548176
15.
The Patient Experience: Symptoms and Impact of Dry Age-Related Macular Degeneration.
Ophthalmol Ther
; 10(1): 151-164, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512689
16.
Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden.
Menopause
; 28(8): 875-882, 2021 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34033602
17.
Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate.
Prostate Cancer Prostatic Dis
; 24(4): 1032-1040, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612825
18.
Patient- and physician-reported outcomes from two phase 3 randomized studies (RAJ3 and RAJ4) of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis.
Arthritis Res Ther
; 23(1): 221, 2021 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34429152
19.
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis.
Rheumatol Ther
; 8(2): 729-750, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33725321
20.
Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.
J Manag Care Spec Pharm
; 26(4): 538-549, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020841